Studies have shown that cancer cells can 'trick' the immune system into believing they are healthy and prevent themselves from getting destroyed.

One of the difficulties is identifying the elements that truly influence the tumour's ability to grow, lead researcher Mikael ...

Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and ...

New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...

Cancer immunotherapy has advanced the field of medicine and cancer care. Specifically, immunotherapy refers to the targeted treatment of the immune system. Over the last few decades, immunotherapy has ...

Cancer cells may be capable of “reprogramming” immune cells to produce a molecule that actively promotes tumour growth, ...

A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response ...

This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis. castration-resistant prostate cancer (CRPC) enhances glucose metabolism, shifts ...

Cancer cells rapidly adapt to treatments, developing resistance that makes chemotherapy less effective. Researchers used an existing anti-inflammatory drug to disrupt cancer cells’ ability to adapt by ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...